Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 107 results.
User Information
Export Records
  1. 1.   Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
  2. Moore, L. E.; Nickerson, M. L.; Brennan, P.; Toro, J. R.; Jaeger, E.; Rinsky, J.; Han, S. S.; Zaridze, D.; Matveev, V.; Janout, V.; Kollarova, H.; Bencko, V.; Navratilova, M.; Szeszenia-Dabrowska, N.; Mates, D.; Schmidt, L. S.; Lenz, P.; Karami, S.; Linehan, W. M.; Merino, M.; Chanock, S.; Boffetta, P.; Chow, W. H.; Waldman, F. M.; Rothman, N.
  3. Plos Genetics. 2011, Oct; 7(10): 13.
  1. 2.   miRNA-7 Attenuation in Schwannoma Tumors Stimulates Growth by Upregulating Three Oncogenic Signaling Pathways
  2. Saydam, O.; Senol, O.; Wurdinger, T.; Mizrak, A.; Ozdener, G. B.; Stemmer-Rachamimov, A. O.; Yi, M.; Stephens, R. M.; Krichevsky, A. M.; Saydam, N.; Brenner, G. J.; Breakefield, X. O.
  3. Cancer Research. 2011, Feb; 71(3): 852-861.
  1. 3.   Carminomycin I Is an Apoptosis Inducer That Targets the Golgi Complex in Clear Cell Renal Carcinoma Cells
  2. Woldemichael, G. M.; Turbyville, T. J.; Linehan, W. M.; McMahon, J. B.
  3. Cancer Research. 2011, Jan; 71(1): 134-142.
  1. 4.   Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production
  2. Zhang, S. L.; Readinger, J. A.; DuBois, W.; Janka-Junttila, M.; Robinson, R.; Pruitt, M.; Bliskovsky, V.; Wu, J. Z.; Sakakibara, K.; Patel, J.; Parent, C. A.; Tessarollo, L.; Schwartzberg, P. L.; Mock, B. A.
  3. Blood. 2011, Jan; 117(4): 1228-1238.
  1. 5.   Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
  2. Kwon, M. J.; Kim, S. S.; Choi, Y. L.; Jung, H. S.; Balch, C.; Kim, S. H.; Song, Y. S.; Marquez, V. E.; Nephew, K. P.; Shin, Y. K.
  3. Carcinogenesis. 2010, Jun; 31(6): 974-983.
  1. 6.   Molecular Diagnosis and Therapy of Kidney Cancer
  2. Linehan, W. M.; Bratslavsky, G.; Pinto, P. A.; Schmidt, L. S.; Neckers, L.; Bottaro, D. P.; Srinivasan, R.
  3. Annual Review of Medicine. 2010, Feb; 61: 329-343.
  1. 7.   Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours
  2. Ivanova, A. V.; Vortmeyer, A.; Ivanov, S. V.; Nickerson, M. L.; Maher, E. R.; Lerman, M. I.
  3. Journal of Pathology. 2008 214(1): 46-57.
  1. 8.   Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
  2. Nickerson, M. L.; Jaeger, E.; Shi, Y.; Durocher, J. A.; Mahurkar, S.; Zaridze, D.; Matveev, V.; Janout, V.; Kollarova, H.; Bencko, V.; Navratilova, M.; Szeszenia-Dabrowska, N.; Mates, D.; Mukeria, A.; Holcatova, I.; Schmidt, L. S.; Toro, J. R.
  3. Clinical Cancer Research. 2008 14(15): 4726-4734.
  1. 9.   BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports
  2. Toro, J. R.; Wei, M. H.; Glenn, G. M.; Weinreich, M.; Toure, O.; Vocke, C.; Turner, M.; Choyke, P.; Merino, M. J.; Pinto, P. A.; Steinberg, S. M.; Schmidt, L. S.; Linehan, W. M.
  3. Journal of Medical Genetics. 2008 45(6): 321-331.
  1. 10.   Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage
  2. Lo, P. H. Y.; Xie, D.; Chan, K. C.; Xu, F. P.; Kuzmin, I.; Lerman, M. I.; Law, S.; Chua, D.; Sham, J.; Lung, M. L.
  3. Cancer Letters. 2007, Nov; 257(2): 199-205.
  1. 11.   Proteomic analysis of protein expression changes in a model of gliomagenesis
  2. McBee, J. K.; Yu, L. R.; Kinoshita, Y.; Uo, T.; Beyer, R. P.; Veenstra, T. D.; Morrison, R. S.
  3. Proteomics Clinical Applications. 2007, Nov; 1(11): 1485-1498.
  1. 12.   Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells
  2. Reinhold, W. C.; Reimers, M. A.; Maunakea, A. K.; Kim, S.; Lababidi, S.; Scherf, U.; Shankavaram, U. T.; Ziegler, M. S.; Stewart, C.; Kouros-Mehr, H.; Cui, H. M.; Dolginow, D.; Scudiero, D. A.; Pommier, Y. G.; Munroe, D. J.; Feinberg, A. P.; Weinstein, J. N.
  3. Molecular Cancer Therapeutics. 2007, Feb; 6(2): 391-403.
  1. 13.   The tetraspanin protein peripherin-2 forms a complex with melanoregulin, a putative membrane fusion regulator
  2. Boesze-Battaglia, K.; Song, H. M.; Sokolov, M.; Lillo, C.; Pankoski-Walker, L.; Gretzula, C.; Gallagher, B.; Rachel, R. A.; Jenkins, N. A.; Copeland, N. G.; Morris, F.; Jacob, J.; Yeagle, P.; Williams, D. S.; Damek-Poprawa, M.
  3. Biochemistry. 2007, Feb; 46(5): 1256-1272.
  1. 14.   Identification of the genes for kidney cancer: Opportunity for disease-specific targeted therapeutics
  2. Linehan, W. M.; Pinto, P. A.; Srinivasan, R.; Merino, M.; Choyke, P.; Choyke, L.; Coleman, J.; Toro, J.; Glenn, G.; Vocke, C.; Zbar, B.; Schmidt, L. S.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2007, Jan; 13(2): 671S-679S.
  1. 15.   Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma
  2. Yau, W. L.; Lung, H. L.; Zabarovsky, E. R.; Lerman, M. I.; Sham, J. S. T.; Chua, D. T. T.; Tsao, S. W.; Stanbridge, E. J.; Lung, M. L.
  3. International Journal of Cancer. 2006, Dec; 119(12): 2821-2826.
  1. 16.   Development of a cell-based reporter assay for screening of inhibitors of hypoxia-inducible factor 2-induced gene expression
  2. Woldemichael, G. M.; Vasselli, J. R.; Gardella, R. S.; McKee, T. C.; Linehan, W. M.; McMahon, J. B.
  3. Journal of Biomolecular Screening. 2006, Sep; 11(6): 678-687.
  1. 17.   Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice
  2. Suzuki, T.; Minehata, K.; Akagi, K.; Jenkins, N. A.; Copeland, N. G.
  3. Embo Journal. 2006, Jul; 25(14): 3422-3431.
  1. 18.   Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells
  2. de la Pena, L.; Burgan, W. E.; Carter, D. J.; Hollingshead, M. G.; Satyamitra, M.; Camphausen, K.; Tofilon, P. J.
  3. Molecular Cancer Therapeutics. 2006, Jun; 5(6): 1504-1510.
  1. 19.   Expression of hypoxia inducible factor-1 alpha and 2 alpha in genetically distinct early renal cortical tumors
  2. Kim, C. M.; Vocke, C.; Torres-Cabala, C.; Yang, Y. F.; Schmidt, L.; Walther, M.; Linehan, W. M.
  3. Journal of Urology. 2006, May; 175(5): 1908-1914.
  1. 20.   Spreading of methylation within RUNX3 CpG island in gastric cancer
  2. Homma, N.; Tamura, G.; Honda, T.; Matsumoto, Y.; Nishizuka, S.; Kawata, S.; Motoyama, T.
  3. Cancer Science. 2006, JAN; 97(1): 51-56.
  1. 21.   An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model
  2. Reilly, K. M.; Broman, K. W.; Bronson, R. T.; Tsang, S.; Loisel, D. A.; Christy, E. S.; Sun, Z. H.; Diehl, J.; Munroe, D. J.; Tuskan, R. G.
  3. Cancer Research. 2006, JAN 1; 66(1): 62-68.
  1. 22.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 23.   High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors
  2. Vocke, C. D.; Yang, Y. F.; Pavlovich, C. P.; Schmidt, L. S.; Nickerson, M. L.; Torres-Cabala, C. A.; Merino, M. J.; Walther, M. M.; Zbar, B.; Linehan, W. M.
  3. Journal of the National Cancer Institute. 2005, JUN 15; 97(12): 931-935.
  1. 24.   Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine
  2. Dote, H.; Cerna, D.; Burgan, W. E.; Carter, D. J.; Cerra, M. A.; Hollingshead, M. G.; Camphausen, K.; Tofilon, P. J.
  3. Clinical Cancer Research. 2005, JUN 15; 11(12): 4571-4579.
  1. 25.   Topotecan blocks hypoxia-inducible factor-1 alpha, and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells
  2. Beppu, Y.; Nakamura, K.; Linehan, W. M.; Rapisarda, A.; Thiele, C. J.
  3. Cancer Research. 2005, JUN 1; 65(11): 4775-4781.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel